- Home
- SKYE vs WSBK Comparison
SKYE vs WSBK Comparison
Compare SKYE & WSBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKYE
- WSBK
- Stock Information
- Founded
- SKYE 2012
- WSBK 2024
- Country
- SKYE United States
- WSBK United States
- Employees
- SKYE N/A
- WSBK N/A
- Industry
- SKYE Biotechnology: Pharmaceutical Preparations
- WSBK
- Sector
- SKYE Health Care
- WSBK
- Exchange
- SKYE Nasdaq
- WSBK NYSE
- Market Cap
- SKYE 80.7M
- WSBK 86.4M
- IPO Year
- SKYE N/A
- WSBK N/A
- Fundamental
- Price
- SKYE $2.30
- WSBK $9.30
- Analyst Decision
- SKYE Buy
- WSBK
- Analyst Count
- SKYE 6
- WSBK 0
- Target Price
- SKYE $16.60
- WSBK N/A
- AVG Volume (30 Days)
- SKYE 237.9K
- WSBK 74.6K
- Earning Date
- SKYE 05-08-2025
- WSBK 01-01-0001
- Dividend Yield
- SKYE N/A
- WSBK N/A
- EPS Growth
- SKYE N/A
- WSBK N/A
- EPS
- SKYE N/A
- WSBK 0.02
- Revenue
- SKYE N/A
- WSBK $15,687,000.00
- Revenue This Year
- SKYE N/A
- WSBK N/A
- Revenue Next Year
- SKYE N/A
- WSBK N/A
- P/E Ratio
- SKYE N/A
- WSBK $564.36
- Revenue Growth
- SKYE N/A
- WSBK N/A
- 52 Week Low
- SKYE $1.14
- WSBK $8.91
- 52 Week High
- SKYE $12.11
- WSBK $10.10
- Technical
- Relative Strength Index (RSI)
- SKYE 57.25
- WSBK N/A
- Support Level
- SKYE $1.96
- WSBK N/A
- Resistance Level
- SKYE $2.28
- WSBK N/A
- Average True Range (ATR)
- SKYE 0.23
- WSBK 0.00
- MACD
- SKYE 0.02
- WSBK 0.00
- Stochastic Oscillator
- SKYE 86.89
- WSBK 0.00
About SKYE Skye Bioscience Inc. Common Stock
Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical candidates include nimacimab, a negative allosteric modulating antibody that inhibits peripheral CB1 receptors, currently being developed for the treatment of obesity and SBI-100 Ophthalmic Emulsion ("SBI-100 OE"), a CB1 agonist (activator), currently being developed for the treatment of glaucoma and ocular hypertension.
About WSBK WINCHESTER BANCORP INC
Winchester Bancorp Inc provides a variety of financial services to individuals and small businesses through its offices in Winchester, Woburn, Danvers and Arlington, Massachusetts. Its primary deposit products are checking, savings and term certificate accounts and its primary lending products are residential and commercial real estate loans.